Henry Schein to Present at the UBS Global Life Sciences Conference
MELVILLE, N.Y., Sept. 17 /PRNewswire-FirstCall/ -- Henry Schein, Inc., (Nasdaq: HSIC), the largest provider of health care products and services to office-based practitioners, announced today that Steven Paladino, Henry Schein's Executive Vice President and Chief Financial Officer, will present at the UBS Global Life Sciences Conference at the Grand Hyatt New York.
Henry Schein's presentation is scheduled to begin at 9 a.m. EDT and can be heard via live webcast by visiting www.henryschein.com, clicking on "Investor Relations" and following the link for "Webcasts." A replay will be available on the Web site following the presentation.
About Henry Schein
Henry Schein, a Fortune 500® company and a member of the NASDAQ 100® Index, is recognized for its excellent customer service and highly competitive prices. The Company's four business groups -- Dental, Medical, International and Technology -- serve more than 600,000 customers worldwide, including dental practitioners and laboratories, physician practices and animal health clinics, as well as government and other institutions. The Company operates through a centralized and automated distribution network, which provides customers in more than 200 countries with a comprehensive selection of more than 90,000 national and Henry Schein private-brand products in stock, as well as more than 100,000 additional products available as special-order items. Henry Schein also provides exclusive, innovative technology offerings for dental, medical and veterinary professionals, including value-added practice management software and electronic health record solutions.
Headquartered in Melville, N.Y., Henry Schein employs more than 13,500 people and has operations or affiliates in 23 countries. The Company's net sales reached a record $6.